New device aims to break vaping addiction without drugs

NCT ID NCT07322432

Recruiting now Disease control Sponsor: VapeAway Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests the VapeAway system, a drug-free program that uses special filters to slowly lower nicotine intake, a sensory tool called the Fix Bar, and digital support to help people stop vaping. About 70 motivated adults who vape daily will use the system for 42 days. Researchers want to see if at least 25% can stay vape-free for 30 days after the program, compared to the usual 7% who quit on their own.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

VapeAway filter system (device with nicotine tapering filters, Fix Bar behavioral tool, and digital support)

What this could lead to

If successful, this could provide a new, drug-free option to help people quit vaping, potentially improving health outcomes for nicotine addiction.

What could go wrong

This is a small, early-phase trial with only 70 participants and no placebo group. Results may not apply to everyone, and the program requires strict adherence to the 42-day protocol.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates